Cross-correlation of cyclosporine
nephrotoxicity
Despite the introduction of triple therapy (cyclosporine, azathioprine, and prednisone) in 1984, nephrotoxicity remains a very common and serious side effect of immunosuppression with cyclosporine. At Papworth Hospital the most significant complication associated with long-term use of cyclosporine in heart-transplant patients is chronic nephrotoxicity, which can be irreversible and lead to endstage renal failure (1). After heart transplantation, isolated or combined increases in results of liver-function tests have also been attributed to cyclosporine toxicity (2) (3) (4) (5) (6) .
The persistence of these complications of cyclosporine therapy in heart transplantation may be partly associated with a perceived or actual requirement for heart-transplant recip-ients to be maintained on relatively high concentrations of cyclosporine in blood, compared with other transplant groups (7) . The objective stratification of individual patients according to their susceptibility to these complications may provide a more rational basis for deciding the appropriate cyclosporine dosage adjustment at any given time.
After
We have carried out time-series analysis of cyclosporine concentrations in blood and biochemical tests of renal and liver function in a group of heart and heart-lung transplant recipients to define any putative temporal cause-andeffect relationships between changes in these measurements in the first three months after transplantation. 
PatIents and Methods

Samples
Time Series Analyses
Biochemical data that did not follow gaussian distribution were normalized by appropriate transformations before statistical analysis (9). Data from each patient were divided into five-day periods from the date of transplantation, and the mean result for each period was calculated. We chose a five-day mean period to overcome the problem of missing daily data in time series analyses; this served to spread data points evenly over the three months during which each patient was studied. The use of five-day means may also have the advantage of diluting the effects of analytical error in daily biochemical measurements as well as errors in the collection time of blood samples for measuring "trough" concentrations of cyclosporine, which may obscure underlying correlations. We determined for each patient the correlation between five-day mean cyclosporine concentrations and five-day mean RF'F or LFF data, when 1WF and LFT data were either in phase with cyclosporine measurements or lagged out of phase by as many as three five-day periods. For example, with one five-day lag, the mean cyclosporine concentrations for days 1 to 5 and 6 to 10 were correlated with mean RF'F or LFF data for days 6 to 10 and ii to 15, respectively, and so on. The correlation coefficients (r) for all 32 patients were then transformed (Fisher transformation) to the quantity z (10), which has an approximately gaussian distribution, by the following formula:
The mean ( ) and standard error (SE) were then calculated for the 32 z values. The 95% confidence interval for the mean was calculated as 
Results
The mean (and SD) concentration of cyclosporine measured by smA in whole blood in the 32 heart and heart--.lung and heart-lung transplant patients was 50% greater than the mean blood cyclosporine concentrations measured in 30 liver-and 30 kidney-transplant recipients studied during the same period in Cambridge.
Cyclosporine and Renal Function
There was a statistically significant negative correlation (i.e., the 95% confidence interval for the true correlation coefficientdid not overlap zero) between both five-day 
DiscussIon
In Cambridge, heart and heart-lung transplant patients are, on average, maintained on 50% higher whole-blood cyclosporine concentrations (sRIA) than are liver and kidney recipients.
The requirement for effective immunosuppression in the prevention of acute rejection is the major clinical priority in the management of heart and heart-lung recipients, the consequence of early graft failure being death.
Heart and heart-lung transplant patients at Papworth were, until recently, also routinely monitored for cyclosporine in both whole blood and plasma. They were, therefore, an ideal group in which to carry out time-series analysis of the relative predictive values of different cyclosporine assays and sample matrices, with respect to their temporal association with biochemical measures of renal and hepatic toxicity. Days Poot.Tx
Fig. 2. Whole-biood
5RIA cyclosporine and plasma creatinine concentration profiles (untransformed) in three "susceptible" hearttransplant recipients (A-C; negative correlation coefficient >0.7 with a one-to five-day lag in creatinine) and one "nonsusceptible" heart-transplant recipIent (0; r <0.3, with no lag or up to three oneto five-day lags in creatinine)
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